article/pii/S0140673624014983 [Additional references continue covering all cited sources from the searches conducted] [1] Semaglutide and cardiovascular outcomes in patients with obesity and prevalent heart failure: a prespecified analysis of the SELECT trial ScienceDirect science/article/pii/S0140673624014983 [2] The SELECT trial of semaglutide in patients with overweight or obesity without diabetes: establishing a new pathway to secondary prevention of cardiovascular disease PubMed pubmed.ncbi.nlm.nih.gov [3] Continued Treatment With Tirzepatide for Maintenance of Weight Reduction in Adults With Obesity: The SURMOUNT-4 Randomized Clinical Trial PubMed pubmed.ncbi.nlm.nih.gov [4] Tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial PubMed pubmed.ncbi.nlm.nih.gov [5] GLP-1 receptor agonists: A novel pharmacotherapy for binge eating (Binge eating disorder and bulimia nervosa)

TrimRx, a telehealth weight-management platform, reports that it connects patients with licensed healthcare providers who evaluate eligibility for GLP-1 and GLP-1/GIP medications through online consultations
A Florida judge on Tuesday dismissed Eli Lillys case against a compounding pharmacy, finding that the drugmaker cannot use state law in its campaign against reformulated versions of the companys top-selling weight-loss and diabetes medication tirzepatide
They offer weekly dosing without injections and serve limited states
It also covers dosing, timing, and possible stacks based on research
This is not well-studied in clinical trials but appears frequently in user reports and is likely related to altered gut hormone signaling that affects the vagus nerve and taste pathways